Tag

Anil Satwani

2 articles

Symbiotec Pharmalab Q1FY27 PAT Declines 53% YoY

Symbiotec Pharmalab reported Q1FY27 consolidated PAT of ₹14.1 crore, down 53% YoY from ₹29.9 crore, due to new business expenses. API business grew 6% YoY with revenue of ₹215.3 crore and maintained ~

Symbiotec Pharmalab Q1FY27 Steady 6% Sales Growth

Symbiotec Pharmalab Limited disclosed its Q1FY27 unaudited results via an investor presentation following its September 2026 IPO, which raised Rs. 1,757 Cr. Q1 sales grew 6% YoY with a 9% EBITDA growt